The drug major had posted a net profit of Rs 291.74 crore for the corresponding period of the previous fiscal, the company said in a statement.
Total income from operations increased to Rs 1,966.69 crore for the fourth quarter from Rs 1,865.58 crore in the year ago quarter.
Also Read
Meanwhile, the board of directors has proposed a dividend of Rs 2 per equity share (face value Rs 2) for the financial year 2013.
Over 2.2 million shares were traded on both the stock exchanges so far.